These results supported an inhibitory effect of TIGIT on CD8+ T cell-mediated anti-tuberculosis immune response, as in vitro TIGIT blockade enhanced effector molecule production, proliferation, and killing of intracellular infected BCG. Here, CD8A is linked to tuberculosis.